The Nanotechnologies in Medicine company (NanoMedTech) has been created in Ukraine to implement advanced products developed by Ukrainian scientists in the sphere of nanotechnologies.
The company was created through the integration of scientific potential and private capital.
At a presentation of the new company at the International Center of Electron-Emitting Technologies at the National Academy of Sciences of Ukraine (NASU) on Friday, it was noted that NanoMedTech is the first company of such a level in Ukraine. The initiators of the company's creation were NASU President Borys Paton, along with the well-known businessman and Industrial Union of Donbass co-owner Serhiy Taruta, who became the first investor in the domestic nanotechnology sector.
"The scientific potential of our country is huge, [and its] scientific developments are unique, but they will remain on paper or flow abroad if they are not invested in by the state or private investors. Therefore it is important to establish mutually beneficial partnerships in the innovation sphere, as a result of which everybody will gain profit. Nanotechnologies are, without exaggeration, the technologies of the future, and we are obliged to think about the future. The main thing is that these developments are to serve people and improve life quality. I see specific social significance of our project, its humanitarian value," Taruta said at the presentation.
The Kyiv Post is disabling its online comment section due to an increase in trolls, violent comments and other personal attacks. Other news organizations worldwide have taken similar steps for the same reasons. The Kyiv Post regrets having to take this action. The newspaper believes in a robust public debate, but the discussion must be constructive and intelligent. For the time being, the Kyiv Post will allow comments on its moderated Facebook group https://www.facebook.com/groups/kyivpost/.
The newspaper will consider hosting online comments again when circumstances allow.
Thank you from the Kyiv Post.
Web links to Kyiv Post material are allowed provided that they contain a URL hyperlink to the
www.kyivpost.com material and a maximum 500-character extract of the story. Otherwise, all materials
contained on this site are protected by copyright law and may not be reproduced without the prior
written permission of Public Media at email@example.com
All information of the Interfax-Ukraine news agency placed on this web site is designed for internal
use only. Its reproduction or distribution in any form is prohibited without a written permission of